Health

Breast cancer patients and survivors in the Asia-Pacific workforce. New Zealand: Rising to a growing challenge

December 11, 2018

Asia

December 11, 2018

Asia
Michael Gold

Managing editor

Michael is a managing editor at Economist Impact. Although Michael has roots in Montreal, he grew up in Palo Alto, California and attended Yale University, where he majored in anthropology. Prior to joining the Economist Group, Michael was a correspondent for Reuters in Taipei, where he covered the technology sector. He has also worked in Beijing and is fluent in Mandarin. 

Contact

Breast cancer patients and survivors in the Asia-Pacific workforce. New Zealand: Rising to a growing challenge is an Economist Intelligence Unit report, sponsored by Pfizer New Zealand Ltd, Auckland, New Zealand. This report draws upon interviews and research conducted in August-September 2018 on the topic of return-to-work for breast cancer survivors in New Zealand. It also draws upon an advisory board of global authorities who provided context and background on this topic.

New Zealand has one of the highest breast cancer rates in the world, and more women are diagnosed every day. It ranks second in Asia-Pacific behind Australia, with a crude incidence rate of 145.1 per 100,000, following closely behind its Western counterparts. Some of New Zealand's key data points can be found below:

New Zealand: key data

  • Crude breast cancer incidence rate per 100,000 (2018): 145.1
  • Breast cancer prevalence (five year) per 100,000 (2018): 599.0
  • Labour force participation rate, general (2017): 80.9%
  • Labour force participation rate, women aged 40-64 (2017): 81.1%
  • Unemployment rate, general (2017): 4.9%
  • Unemployment rate, women aged 40-64 (2017): 2.5%

Download the report to find out more.

Enjoy in-depth insights and expert analysis - subscribe to our Perspectives newsletter, delivered every week